LeMaitre Vascular, Inc. Overview
Pro stress-test →LeMaitre Vascular develops and manufactures specialized medical devices used by vascular surgeons to treat peripheral vascular disease and other circulatory conditions. The company operates across the Americas, Europe, EMEA, and APAC regions with a focused portfolio of proprietary biologic and synthetic vascular products.
Strategic Profile
Pro stress-test →LeMaitre's 14% annualized revenue growth over the last five years was solid and beat the average healthcare company, showing its offerings resonate with customers. The company is positioned as a key player in the niche market of vascular surgery devices. Recent momentum is fueled by international expansion, particularly in EMEA and APAC regions, and strong product performance in high-margin categories.
Competitive Landscape
Pro stress-test →LeMaitre competes in the specialized vascular surgery device market against larger diversified medical device companies like Medtronic and Stryker, as well as smaller niche competitors. LeMaitre's strong brand presence and portfolio of well-known products including Artegraft, XenoSure, and RestoreFlow are recognized for quality and reliability, which fosters customer loyalty and supports premium pricing strategies, with brand equity being a significant asset in a market where surgeon preference and product reputation drive purchasing decisions.
Industry Context
LeMaitre Vascular, Inc. operates in Medical Devices - Vascular Surgery.
Key facts
Founded: 1983 · Headquarters: Burlington, Massachusetts, US · Revenue: $250M (2025E) · Market cap: $2.45B